Wilson, USA

Fresenius Kabi acquired the Wilson manufacturing plant from American medical technology company Becton Dickinson and Company (BD) in January 2016. The facility was part of BD’s Rx business. Approved by the US Food and Drug Administration (FDA) in 2012, the facility is equipped with state-of-the-art manufacturing and packaging technologies. It develops various drugs in ready-to-administer pre-filled syringes. The Wilson facility is one of the country’s largest biotechnology centres. 

Technologies:

  • Pre-filled syringes filling

Products:

 

Containers:

Certificates:

  • US-FDA

Market:

  • USA